As reviewed in Medscape Medical News:
Here’s the case scenario the practitioners were asked to review and comment on:
— Cognitive behavior therapy.
— Interpersonal therapy.
— A selective serotonin reuptake inhibitor (SSRI).
— A serotonin-norepinephrine reuptake inhibitor (SNRI).
— A tricyclic antidepressant.
Most clinicians recommended first-line treatment with psychotherapy. SSRIs were the most common type of medication chosen.
“The group acknowledges that their study is limited in that it was about an uncomplicated pregnancy and did not get information about specific drugs. They conclude that clinicians who are managing depression during pregnancy are opting for treatments with good safety profiles. They add that this study highlights the importance of disseminating rapidly changing research findings to front-line practitioners. Dr. Petersen observed: “We are trying to make sure people have a balanced view. When you are looking at risk/benefit ratios, in many cases there is more of a risk to not treat the depression with medication than to treat it with medication.” American Psychiatric Association 160th Annual Meeting: Abstract NR719. May 19-24, 2007.